Key result
HLA-DR4 antigen is linked to ~2-fold higher frequency in patients with essential hypertension.
Case-Control (n=89)
Answers are grounded in this paper and cite their sources.
Association study reveals increased HLA-DR4 frequency in Brazilian Caucasian patients with essential hypertension, indicating its role as a genetic susceptibility marker.
Data from a previous study concerning the distribution of human leukocyte antigen (HLA) haplotypes in siblings with essential hypertension suggested that at least one of the genes responsible for the genetic susceptibility to this disease is located in or near the HLA complex. The objective of the present study was to investigate if a given HLA-A, B, or DR gene could represent a marker for susceptibility to essential hypertension at the population level. Thus, the frequencies of HLA antigens were determined in Caucasian patients with essential hypertension (HLA-A and B antigens were determined in 89 cases, 85 of which were also typed for HLA-DR antigens). The results showed an increased frequency (p = 0.00064) of HLA-DR4, which was present in 34% of the patients and in 16% of local ethnically matched control subjects. We conclude that HLA-DR4 may represent a marker for susceptibility to essential hypertension in the Brazilian Caucasian population.
No takes yet. Share an insight, caveat, or question.
Gerbase‐DeLima et al. (1992) conducted a case-control in Essential hypertension (n=89). HLA-A, B, and DR antigens (specifically HLA-DR4) vs. Local ethnically matched control subjects was evaluated on Frequency of HLA-DR4 antigen (p=0.00064). HLA-DR4 antigen was more frequent in Brazilian Caucasian patients with essential hypertension than in ethnically matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: